Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ALPMY

Recent news which mentions ALPMY

JP Morgan Cut Apellis' Price Forecasts, Cites Longer Peak Sales Timing For Syfovre
Tickers ALPMF ALPMY APLS NEWS
Tags Price Target General Briefs
From Benzinga
Pfizer/Astellas Tout Encouraging Data From Keytruda Combo Regime In Urothelial Cancer Showing 49% Reduction In Death Risk Vs. Chemo
Tickers ALPMF ALPMY NEWS PFE
Tags Briefs General Market News
From Benzinga
Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise
Tickers ALPMF ALPMY ELEV
Tags Expert Ideas Top Stories Initiation
From Benzinga
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
Tickers ALPMF ALPMY NEWS PFE
Tags News SGMO Top Stories
From Benzinga
1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst
Tickers ALPMY APLS
Tags ALPMY APLS Recent Press Releases
From Motley Fool
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
Tickers ALPMF ALPMY APLS NEWS
Tags Trading Ideas Benzinga Stories That Matter
From Benzinga
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
Tickers ALPMF ALPMY AZN MRK
Tags Top Stories AZN News
From Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
Tickers ABBV ALPMY BIIB BMED
Tags BMED Health Care MRK
From Benzinga
White House asserts authority to break patents of certain high-cost drugs
Tickers ALPMY PFE
Tags PFE ALPMY
From MarketWatch
Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study
Tickers ALPMF ALPMY MRK SGEN
Tags Biotech ALPMY Benzinga
From Benzinga
Here Are the 3 George Soros Stocks Most Likely to Turn $200,000 Into $1 Million Over the Next 20 Years
Tickers ALPMY AMZN GOOG GOOGL
Tags Market News GOOGL GOOG
From Motley Fool
Why Is Seagen Stock Trading Higher Today?
Tickers ALPMF ALPMY MRK SGEN
Tags ALPMF Market News Movers
From Benzinga
What's Going On With Neurology Focused Taysha Gene Therapies Stock Today?
Tickers ALPMF ALPMY TSHA
Tags TSHA Contracts FDA
From Benzinga
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
Tickers ALPMY BLU FHLC FXH
Tags Health Care BLU PFE
From Benzinga
Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
Tickers ALPMF ALPMY
Tags Briefs General Health Care
From Benzinga
Why Shares of Annexon Are Plummeting Thursday
Tickers ALPMY ANNX APLS ISEE
Tags Market News ANNX ISEE
From Motley Fool
Google Launches Tools To Detect Fake Images, Apple May Encounter Delays In iPhone 15 Production, Shake Shack Sees Activist Investor Proxy Fight: Today's Top Stories
Tickers AAPL ALPMF ALPMY BTI
Tags Biotech GOOG Health Care
From Benzinga
Astellas' Menopause Drug Sores FDA Approval, After Regulatory Setback
Tickers ALPMF ALPMY
Tags Briefs General Health Care
From Benzinga
Foreign businesses in China fear they’re being targeted in a ‘campaign’ of government crackdowns. It’s probably not that simple.
Tickers ALPMY MU
Tags JP:4503 ALPMY MU
From MarketWatch
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
Tickers ALPMY APLS ISEE TGTX
Tags TGTX Market News VKTX
From Motley Fool
Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%
Tickers ALPMF ALPMY PFE
Tags General PFE Health Care
From Benzinga
First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories
Tickers ADDYY ALPMY BLMN BNTX
Tags Data Processing & Outsourced Services Market News Industrials
From Benzinga
Nasdaq, S&P 500 Futures On Edge Over First Republic Failure, Tech Earnings: Analyst Pins Hopes On Fed's Next Move
Tickers ALPMY CHKP FRC GPN
Tags Futures FRC Economics
From Benzinga
Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'
Tickers ALPMF ALPMY ISEE
Tags why it's moving Biotech ALPMY
From Benzinga
FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer
Tickers ALPMF ALPMY MRK SGEN
Tags Health Care MRK Benzinga
From Benzinga
Japanese Government Urges China To Release Astellas Pharma's Employee
Tickers ALPMF ALPMY
Tags Markets Benzinga Health Care
From Benzinga
Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug
Tickers ALPMF ALPMY PFE
Tags General Briefs Market News
From Benzinga
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
Tickers ABBV ALPMY BMY JNJ
Tags Market News Large Cap ABBV
From Benzinga
Super Bowl Commercials 2023: The Complete List Of Super Bowl LVII Ads And The Companies Behind Them
Tickers ALPMY AMZN BKNG BUD
Tags Snoop Dogg PDYPY TAP
From Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Tickers ALPMF ALPMY HZNP SELB
Tags Analyst Color HZNP News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.